☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Eli Lilly Reports the Availability of Taltz (ixekizumab) as New Citrate-Free Formulation to Reduce Injection Site Pain in the US
August 8, 2022
HUTCHMED and AstraZeneca Report P-II (SAVANNAH) Trial Results of Tagrisso + Savolitinib for EGFR-Mutated NSCLC
August 8, 2022
HUTCHMED Reports P-III (FRESCO-2) Trial Results of Fruquintinib for the Treatment of Metastatic Colorectal Cancer
August 8, 2022
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) Receive the US FDA’s Approval as First HER2-Directed Therapy for...
August 8, 2022
Genmab Expands its 2015 Agreement with BioNTech to Develop and Commercialize Novel Immunotherapy for Cancer
August 8, 2022
Myovant and Pfizer’s Myfembree Receive the US FDA’s Approval for the Treatment of Pain Associated with Endometriosis
August 8, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions